Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Spread the love“`html For anyone running an online store, a smoothly functioning shopping cart is crucial. However, many WooCommerce users find themselves facing a frustrating issue: the WooCommerce ...

Not all streaming services treat VPNs the same. Here's how major platforms differ, why some VPNs are blocked, and your best ...

Spread the love“`html JavaScript is the backbone of modern web functionality. Without it, many websites would be nothing more than static pages with basic information. If you’ve ever encountered a ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The project has been dogged by concerns about the impact of noise and vibration on the crew, and the Public Accounts Committee warned there were “unrealistic expectations” about how soldiers will be ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with ‌strict controls ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

April 27 (Reuters) - Eli Lilly ⁠said ⁠on Monday it would ⁠buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to ‌expand its oncology ...